Association Hypoxia Inducible Factors-1 Alpha (HIF-1 α) Levels and  Epithelial Ovarian Cancer (EOC)

Asmuliadi Asis; Nugraha Utama Pelupessy; Johnsen Mailoa; Maisuri Tajuddin Chalid

doi:10.24198/obgynia/v6n1.438

Association Hypoxia Inducible Factors-1 Alpha (HIF-1 α) Levels and Epithelial Ovarian Cancer (EOC)

Asmuliadi Asis,^(1*) Nugraha Utama Pelupessy,⁽²⁾ Johnsen Mailoa,⁽³⁾ Maisuri Tajuddin Chalid,⁽⁴⁾

(1) Hasanuddin University
(2) Department of Obstetrics and Gynecology, Faculty of Medicine, Hasanuddin University Makasar
(3) Department of Obstetrics and Gynecology, Faculty of Medicine, Hasanuddin University Makasar
(4) Department of Obstetrics and Gynecology, Faculty of Medicine, Hasanuddin University Makasar
(*) Corresponding Author

Abstract

Objective: This study was conduct to investigate the association of the HIF-1α with stage,hystological type of ephitelial ovarian cancer (EOC).
Methods: This study is an observational study with a cross-sectional design on 72 women diagnosed with epithelial ovarian carcinoma who underwent surgical staging in a period of 2017 to 2019 in Wahidin Sudirohusodo Hospital. Measurement of HIF1a concentration was performed and further categorized into weak, moderate and strong and then analyzed with age, parity, history of abortion, ascites, type of histopathology, cancer stage and CA-125 serum level.
Result: There’s a significant relationship between HIF-1a expression and stage (p<0.05), where moderate expression of HIF1a was the most dominant with a total of 32 (44.4%) people. Moderate-to-strong expression of HIF1a was found more in patients with epithelial ovarian carcinoma than weak-to-negative HIF1a expression. More patients with stage III-IV ovarian carcinoma were found with moderate-to-strong HIF1a expression (51 people).
Conclusion: HIF1a expression was found to be increased along with the progression of epithelial ovarian cancer stage where positive HIF1a expression was found more in patients with stage III/IV compared to stage I/II.

Hubungan Antara Kadar Hypoxia Inducible Factors-1 Alpha (HIF-1 α) dengan Karsinoma Ovarium Tipe Epitelial

Abstrak
Tujuan: Penelitian ini bertujuan untuk mengetahui hubungan antara kadar HIF-1 alpha dan karsinoma ovarium tipe epithelial
Metode: Penelitian ini menggunakan desain case-control pada 72 perempuan dengan karsinoma ovarium tipe epitelial yang telah menjalani surgical staging selama tahun 2017 hingga 2019 di RS Wahidin Sudirohusodo. Peneliti mengukur kadar HIF1a dan mengkategorikan dalam negatif, lemah, sedang, dan kuat serta menilai hubungannya dengan usia, paritas, riwayat abortus, ascites, jenis histologi, stadium kanker ovarium, dan kadar CA-125.
Hasil: Terdapat hubungan antara stadium dan ekspresi HIF1a (p<0.05). HIF1a dengan ekspresi-sedang didapatkan paling banyak yaitu 32 (44.4%) orang. Lebih banyak ditemukan ekspresi HIF1a sedang-kuat pada pasien karsinoma ovarium tipe epithelial dibandingkan ekspresi HIF1a negatif-lemah. Pasien karsinoma ovarium stadium 3-4 lebih banyak ditemukan dengan ekspresi HIF1a sedang-kuat (51 orang).
Kesimpulan: Terdapat hubungan yang bermakna antara ekspresi HIF1a dan stadium kanker ovarium tipe epitelial yaitu ekspresi positif HIF1a lebih banyak ditemukan pada pasien dengan stadium III/IV dibandingkan stadium I/II.

Kata kunci: Karsinoma ovarium tipe epitelial, Hypoxia Inducible Factor 1 alpha (HIF1a), stadium kanker

Keywords

Ovarian cancer, HIF-1a, stage, immunohistochemical

Full Text:

PDF

References

Modugno F, Edwards RP. Ovarian cancer: prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report. Int J Gynecol Cancer [Internet]. 2012;22(8):S45-57. Available from: http://europepmc.org/abstract/MED/23013733

Arora, Taruna; Mullangi Sanjana; Reddy Lekkala M. Ovarian Cancer - StatPearls - NCBI Bookshelf [Internet]. 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK567760/

Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989 Dec;49(23):6449–65.

Wang X, Du Z, Xu T, Wang X, Li W, Gao J, et al. HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies. Front Oncol. 2021;11(December):1–15.

Liu Z, Wu Z, Fan Y, Fang Y. An overview of biological research on hypoxia-inducible factors (HIFs). Endokrynol Pol. 2020;71(5):432–40.

Harris AL. Hypoxia - A key regulatory factor in tumour growth. Nature Reviews Cancer. 2002.

Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of Hypoxia-inducible Factor 1α Is a Marker for an Unfavorable Prognosis in Early-Stage Invasive Cervical Cancer1. Cancer Res. 2000 Sep 1;60(17):4693–6.

Harris AL. Hypoxia - A key regulatory factor in tumour growth. Nature Reviews Cancer. 2002.

Cheng JC, Klausen C, Leung PCK. Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer Lett [Internet]. 2013;329(2):197–206. Available from: http://dx.doi.org/10.1016/j.canlet.2012.10.029

Shen W, Li HL, Liu L, Cheng JX. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer. Eur Rev Med Pharmacol Sci. 2017;21(11):2596–603.

Daponte A, Ioannou M, Mylonis I, Simos G, Minas M, Messinis IE, et al. Prognostic significance of hypoxia-inducible factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: An immunohistochemical study. BMC Cancer. 2008;

Silver DL, Naora H, Liu J, Cheng W, Montell DJ. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res. 2004 May;64(10):3550–8.

Han X, Lu Y, Li X, Xia L, Wen H, Feng Z, et al. Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia. Front Oncol. 2021;

Cao D, Hou M, Guan Y, Jiang M, Yang Y, Gou H. Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer [Internet]. 2009;9(1):432. Available from: https://doi.org/10.1186/1471-2407-9-432

Masoumi Moghaddam S, Amini A, Morris DL, Pourgholami MH. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev [Internet]. 2012;31(1):143–62. Available from: https://doi.org/10.1007/s10555-011-9337-5

Shih HJ, Chang HF, Chen CL, Torng PL. Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer. Sci Rep [Internet]. 2021;11(1):1–13. Available from: https://doi.org/10.1038/s41598-021-02400-1

Seeber LMS, Horrée N, Vooijs MAGG, Heintz APM, van der Wall E, Verheijen RHM, et al. The role of hypoxia inducible factor-1alpha in gynecological cancer. Crit Rev Oncol Hematol. 2011 Jun;78(3):173–84.

Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther [Internet]. 2007/11/14. 2008 Feb;7(2):255–64. Available from: https://pubmed.ncbi.nlm.nih.gov/18059191

DOI: http://dx.doi.org/10.24198/obgynia/v6n1.438